BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30015971)

  • 1. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C
    Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis.
    Dong XZ; Zhao ZR; Hu Y; Lu YP; Liu P; Zhang L
    Gastric Cancer; 2020 Mar; 23(2):260-272. PubMed ID: 31650323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy.
    Tang H; Xu Y; Zhang Z; Zeng S; Dong W; Jiao W; Hu X
    Mol Med Rep; 2019 May; 19(5):3696-3706. PubMed ID: 30896799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the HIF‑1α/SDF‑1/CXCR4 signaling axis in accelerated fracture healing after craniocerebral injury.
    Xue Y; Li Z; Wang Y; Zhu X; Hu R; Xu W
    Mol Med Rep; 2020 Oct; 22(4):2767-2774. PubMed ID: 32945380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
    Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDF‑1/CXCR4 axis induces apoptosis of human degenerative nucleus pulposus cells via the NF‑κB pathway.
    Liu Z; Ma C; Shen J; Wang D; Hao J; Hu Z
    Mol Med Rep; 2016 Jul; 14(1):783-9. PubMed ID: 27220474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.
    Barbieri F; Bajetto A; Porcile C; Pattarozzi A; Massa A; Lunardi G; Zona G; Dorcaratto A; Ravetti JL; Spaziante R; Schettini G; Florio T
    Ann N Y Acad Sci; 2006 Dec; 1090():332-43. PubMed ID: 17384278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.
    Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D
    Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDF1/CXCR4 axis facilitates the angiogenesis via activating the PI3K/AKT pathway in degenerated discs.
    Zhang H; Wang P; Zhang X; Zhao W; Ren H; Hu Z
    Mol Med Rep; 2020 Nov; 22(5):4163-4172. PubMed ID: 32901877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
    Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
    Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
    Bajetto A; Barbieri F; Pattarozzi A; Dorcaratto A; Porcile C; Ravetti JL; Zona G; Spaziante R; Schettini G; Florio T
    Neuro Oncol; 2007 Jan; 9(1):3-11. PubMed ID: 17108064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis.
    Ito N; Sakamoto K; Hikichi C; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F741-F753. PubMed ID: 32068458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M; Matsuo Y; Koide S; Tsuboi K; Shamoto T; Sato T; Saito K; Takahashi H; Takeyama H
    BMC Cancer; 2016 May; 16():305. PubMed ID: 27175473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
    Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
    Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.
    Ananthula S; Sinha A; El Gassim M; Batth S; Marshall GD; Gardner LH; Shimizu Y; ElShamy WM
    Oncotarget; 2016 Apr; 7(15):20869-89. PubMed ID: 26989079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.